EUR 300.27 For Business Accounts Only

Pharmaceuticals in South Korea

Summary

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The South Korean pharmaceuticals market had total revenues of $30.6 billion in 2022, representing a compound annual growth rate (CAGR) of 5.2% between 2017 and 2022.
- 0
- The South Korean market acquired a 7.2% share of the Asia-Pacific pharmaceuticals market in 2022. South Korea's pharmaceutical market is expected to remain strong despite concerns about a lag in drug approvals. The government's support for the industry, as seen in recent legislation, enhanced its long-term potential.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Korea
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts

Reasons To Buy

- What was the size of the South Korea pharmaceuticals market by value in 2022?
- What will be the size of the South Korea pharmaceuticals market in 2027?
- What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up South Korea's pharmaceuticals market?